Heterogeneity of the molecular biology of methemoglobinemia: A study of eight consecutive patients

Haematologica

Volumn 90, Issue 5, 2005, Pages 687-689

  Maran, Jey ^a   Guan, Yongli ^a   Ou, Ching Nan ^a   Prchal, Josef T ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

B5R mutations; Methemoglobinemia

Indexed keywords

CYTOCHROME B5 REDUCTASE; MESSENGER RNA;

ARTICLE; CLINICAL ARTICLE; DNA DETERMINATION; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; INTRON; METHEMOGLOBINEMIA; MOLECULAR BIOLOGY; RNA PROCESSING; RNA SPLICING;

AMINO ACID SUBSTITUTION; CYTOCHROME-B(5) REDUCTASE; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; INTRONS; LIDOCAINE; MALE; METHEMOGLOBINEMIA; MUTATION, MISSENSE; POINT MUTATION; RNA, MESSENGER;

EID: 20344364180     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Evelyn KA, Malloy HT. Microdetermination of oxyhemoglobin, methemoglobin and sulfhemoglobin in a single sample of blood. J Biol Chem 1938;126:655.
2. Ou CN, Rognerud CL. Diagnosis of hemoglobinopathies: electrophoresis vs. HPLC. Clin Chim Acta 2001;313:187-94.
3. Jenkins MM, Prchal JT. A novel mutation found in the 3′ domain of NADH-cytochrome B5 reductase in an African-American family with type I congenital methemoglobinemia. Blood 1996;87:2993-9.
4. Chen L, Segal DM, Mash DC. Semi-quantitative reverse-transcriptase polymerase chain reaction: an approach for the measurement of target gene expression in human brain. Brain Res Brain Res Protoc 1999;4:132-9.
5. Liu E, Jelinek J, Pastore YD, Guan Y, Prchal JF, Prchal JT. Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin. Blood 2003;101:3294-301.
6. Dekker J, Eppink MH, van Zwieten R, de Rijk T, Remacha AF, Law LK, et al. Seven new mutations in the nicotinamide adenine dinucleotide reduced-cytochrome b(5) reductase gene leading to methemoglobinemia type I. Blood 2001;97:1106-14.
7. Vieira LM, Kaplan JC, Kahn A, Leroux A. Four new mutations in the NADH-cytochrome b5 reductase gene from patients with recessive congenital methemoglobinemia type II. Blood 1995;85:2254-62.
8. Holbrook JA, Neu-Yilik G, Hentze MW, Kulozik AE. Nonsense-mediated decay approaches the clinic. Nat Genet 2004;36:801-8.
9. Cohen RJ, Sachs JR, Wicker DJ, Conrad ME. Methemoglobinemia provoked by malarial chemoprophylaxis in Vietnam. N Engl J Med 1968;279:1127-31.